Not recruiting
B precursor type acute leukaemia+3
Not recruitingStudy on CLIC-1901 CAR T-cells and Tocilizumab for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin Lymphoma
Registered drugNo placebo
Study on CLIC-1901 CAR T-cells and Tocilizumab for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin Lymphoma
Registered drugNo placebo
- Disease:B precursor type acute leukaemiaB-cell small lymphocytic lymphoma+2
- Substances:Clic-1901 CartTocilizumab
Countries:
Denmark
Denmark- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Clic-1901 Cart